It is estimated that in 2022, 24,600 Canadians will be diagnosed with prostate cancer, and 4,600 Canadians will die from it. This represents 10% of male cancer deaths in the country.
The new treatment is indicated for men who have previously received at least one androgen receptor signaling pathway inhibitor and taxane-based chemotherapy.
Long-term side effects of radical prostatectomies often require input from a number of specialists, including family physicians. How much do you know about recovery from prostate cancer surgery?